+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Azithromycin Market - Global Forecast 2026-2032- Product Image
Azithromycin Market - Global Forecast 2026-2032- Product Image
New

Azithromycin Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 184 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6082440
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The global azithromycin market plays a crucial role in meeting the evolving clinical and commercial demands of antibiotics worldwide. Against a backdrop of regulatory shifts and technological advancements, stakeholders are recalibrating strategies to ensure reliable access and competitive differentiation.

Market Snapshot: Azithromycin Market Size and Growth

In 2025, the azithromycin market reached USD 7.83 billion and is projected to increase to USD 8.28 billion in 2026. The sector is expected to expand at a compound annual growth rate (CAGR) of 5.88%, attaining USD 11.68 billion by 2032.

Scope & Segmentation

This report delivers an in-depth analysis of the azithromycin market, addressing product diversity, regional dynamics, and evolving commercial environments. Market segmentation is designed to inform targeted decision-making:

  • Product Type: Distinction between branded and generic formulations, each leveraging innovation, patient support, pricing, or supply reliability.
  • Dosage Forms: Capsules, tablets, and suspensions tailored to various populations, including pediatric and adult patients.
  • Route of Administration: Oral and intravenous options that enable both outpatient and inpatient therapy, facilitating transition-of-care protocols.
  • Clinical Indications: Use cases such as gastrointestinal, respiratory, sexually transmitted, and skin-related infections with further sub-segmentation for nuanced prescribing behavior.
  • End Users: Acute and chronic care environments including ambulatory care, clinics, homecare, and hospitals, each with specific procurement and deployment priorities.
  • Sales Channels: Drug stores, hospital pharmacies, retail networks, and online pharmacy models supporting omnichannel distribution while ensuring compliance.
  • Geographic Regions: Americas, Europe Middle East & Africa, and Asia-Pacific, each with unique access pathways, manufacturing hubs, and regulatory complexities.

Key Takeaways for Senior Decision-Makers

  • Azithromycin retains clinical indispensability due to its broad-spectrum applications and versatile formulation landscape, vital for both acute and community-based settings.
  • The market faces a bifurcation: branded products focus on differentiation and support, while generics deliver value through efficiency and supply security.
  • Procurement strategies are evolving in direct response to regulatory requirements, antimicrobial stewardship, pricing pressures, and the need for supply continuity.
  • Distribution models are transforming, with expanding online and retail pharmacy channels broadening reach but also introducing new compliance demands.
  • Regional heterogeneity drives distinct challenges: the Americas emphasize contracting and reimbursement, Europe Middle East & Africa address access and regulation, and Asia-Pacific highlights manufacturing scale and distribution agility.

Tariff Impact: Strategic Shifts in the Azithromycin Market

The 2025 introduction of tariffs on active pharmaceutical ingredients and finished dosage forms has accelerated market restructuring. Manufacturers and procurement leaders now prioritize domestic production, diversify supply partnerships, and leverage regional manufacturing capabilities to mitigate exposure and maintain supply stability. Procurement contracts often include provisions for tariff risk, price adjustments, and bonded warehousing, enhancing resilience at both manufacturer and health system levels.

Methodology & Data Sources

The analysis is grounded in primary interviews with clinicians, pharmacists, and procurement professionals, supported by secondary research from peer-reviewed literature, surveillance data, and regulatory agency reports. Supply-chain mapping, site certification verifications, and cross-validation against operational data strengthen the accuracy of insights presented in this report.

Why This Report Matters

  • Senior leaders gain actionable intelligence to support procurement, contracting, and risk mitigation aligned with clinical and operational priorities.
  • Tailored segmentation helps identify growth opportunities and adapt to region-specific regulatory changes.
  • Evidence-based insights enable formulation of resilient, forward-looking commercial strategies that balance clinical utility and supply reliability.

Conclusion

Azithromycin’s enduring clinical value is matched by increasing strategic complexity. Leaders who adapt supply, maintain quality, and engage proactively with evolving distribution and regulatory frameworks are best placed for sustained success and risk-managed growth in the sector.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Azithromycin Market, by Product Type
8.1. Branded
8.2. Generic
9. Azithromycin Market, by Dosage Form
9.1. Capsule
9.2. Suspension
9.3. Tablet
10. Azithromycin Market, by Route Of Administration
10.1. Intravenous
10.2. Oral
11. Azithromycin Market, by Indication
11.1. Gastrointestinal Infections
11.2. Respiratory Infections
11.2.1. Lower Respiratory Infections
11.2.2. Upper Respiratory Infections
11.3. Sexually Transmitted Infections
11.3.1. Chlamydia Infections
11.3.2. Gonorrhea
11.4. Skin Infections
11.4.1. Acute Bacterial Skin Structure Infections
11.4.2. Soft Tissue Infections
12. Azithromycin Market, by End User
12.1. Ambulatory Care
12.2. Clinics
12.3. Homecare
12.4. Hospitals
13. Azithromycin Market, by Sales Channel
13.1. Drug Store
13.2. Hospital Pharmacy
13.3. Online Pharmacy
13.4. Retail Pharmacy
14. Azithromycin Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Azithromycin Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Azithromycin Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Azithromycin Market
18. China Azithromycin Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. Aurobindo Pharma
19.6. Cipla Ltd.
19.7. Dr. Reddy's Laboratories Ltd.
19.8. Hikma Pharmaceuticals PLC
19.9. Lupin Limited
19.10. Lupin Limited
19.11. Pfizer Inc.
19.12. Sandoz International GmbH
19.13. Sun Pharmaceutical Industries Ltd.
19.14. Teva Pharmaceutical Industries Ltd.
19.15. Viatris Inc.
19.16. Zydus Lifesciences Ltd.
List of Figures
FIGURE 1. GLOBAL AZITHROMYCIN MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL AZITHROMYCIN MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL AZITHROMYCIN MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL AZITHROMYCIN MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL AZITHROMYCIN MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL AZITHROMYCIN MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL AZITHROMYCIN MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL AZITHROMYCIN MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES AZITHROMYCIN MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA AZITHROMYCIN MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL AZITHROMYCIN MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL AZITHROMYCIN MARKET SIZE, BY BRANDED, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL AZITHROMYCIN MARKET SIZE, BY BRANDED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL AZITHROMYCIN MARKET SIZE, BY BRANDED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL AZITHROMYCIN MARKET SIZE, BY GENERIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL AZITHROMYCIN MARKET SIZE, BY GENERIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL AZITHROMYCIN MARKET SIZE, BY GENERIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL AZITHROMYCIN MARKET SIZE, BY CAPSULE, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL AZITHROMYCIN MARKET SIZE, BY CAPSULE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL AZITHROMYCIN MARKET SIZE, BY CAPSULE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL AZITHROMYCIN MARKET SIZE, BY SUSPENSION, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL AZITHROMYCIN MARKET SIZE, BY SUSPENSION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL AZITHROMYCIN MARKET SIZE, BY SUSPENSION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL AZITHROMYCIN MARKET SIZE, BY TABLET, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL AZITHROMYCIN MARKET SIZE, BY TABLET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL AZITHROMYCIN MARKET SIZE, BY TABLET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL AZITHROMYCIN MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL AZITHROMYCIN MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL AZITHROMYCIN MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL AZITHROMYCIN MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL AZITHROMYCIN MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL AZITHROMYCIN MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL AZITHROMYCIN MARKET SIZE, BY LOWER RESPIRATORY INFECTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL AZITHROMYCIN MARKET SIZE, BY LOWER RESPIRATORY INFECTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL AZITHROMYCIN MARKET SIZE, BY LOWER RESPIRATORY INFECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL AZITHROMYCIN MARKET SIZE, BY UPPER RESPIRATORY INFECTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL AZITHROMYCIN MARKET SIZE, BY UPPER RESPIRATORY INFECTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL AZITHROMYCIN MARKET SIZE, BY UPPER RESPIRATORY INFECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL AZITHROMYCIN MARKET SIZE, BY CHLAMYDIA INFECTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL AZITHROMYCIN MARKET SIZE, BY CHLAMYDIA INFECTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL AZITHROMYCIN MARKET SIZE, BY CHLAMYDIA INFECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL AZITHROMYCIN MARKET SIZE, BY GONORRHEA, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL AZITHROMYCIN MARKET SIZE, BY GONORRHEA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL AZITHROMYCIN MARKET SIZE, BY GONORRHEA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL AZITHROMYCIN MARKET SIZE, BY ACUTE BACTERIAL SKIN STRUCTURE INFECTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL AZITHROMYCIN MARKET SIZE, BY ACUTE BACTERIAL SKIN STRUCTURE INFECTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL AZITHROMYCIN MARKET SIZE, BY ACUTE BACTERIAL SKIN STRUCTURE INFECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL AZITHROMYCIN MARKET SIZE, BY SOFT TISSUE INFECTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL AZITHROMYCIN MARKET SIZE, BY SOFT TISSUE INFECTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL AZITHROMYCIN MARKET SIZE, BY SOFT TISSUE INFECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL AZITHROMYCIN MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL AZITHROMYCIN MARKET SIZE, BY AMBULATORY CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL AZITHROMYCIN MARKET SIZE, BY AMBULATORY CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL AZITHROMYCIN MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL AZITHROMYCIN MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL AZITHROMYCIN MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL AZITHROMYCIN MARKET SIZE, BY HOMECARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL AZITHROMYCIN MARKET SIZE, BY HOMECARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL AZITHROMYCIN MARKET SIZE, BY HOMECARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL AZITHROMYCIN MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL AZITHROMYCIN MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL AZITHROMYCIN MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL AZITHROMYCIN MARKET SIZE, BY DRUG STORE, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL AZITHROMYCIN MARKET SIZE, BY DRUG STORE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL AZITHROMYCIN MARKET SIZE, BY DRUG STORE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL AZITHROMYCIN MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL AZITHROMYCIN MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL AZITHROMYCIN MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL AZITHROMYCIN MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL AZITHROMYCIN MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL AZITHROMYCIN MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL AZITHROMYCIN MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL AZITHROMYCIN MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL AZITHROMYCIN MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL AZITHROMYCIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. AMERICAS AZITHROMYCIN MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 88. AMERICAS AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 89. AMERICAS AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 90. AMERICAS AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 91. AMERICAS AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 92. AMERICAS AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2032 (USD MILLION)
TABLE 93. AMERICAS AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2032 (USD MILLION)
TABLE 94. AMERICAS AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2032 (USD MILLION)
TABLE 95. AMERICAS AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 96. AMERICAS AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 97. NORTH AMERICA AZITHROMYCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. NORTH AMERICA AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 99. NORTH AMERICA AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 100. NORTH AMERICA AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 101. NORTH AMERICA AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 102. NORTH AMERICA AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2032 (USD MILLION)
TABLE 103. NORTH AMERICA AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2032 (USD MILLION)
TABLE 104. NORTH AMERICA AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2032 (USD MILLION)
TABLE 105. NORTH AMERICA AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 106. NORTH AMERICA AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 107. LATIN AMERICA AZITHROMYCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. LATIN AMERICA AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 109. LATIN AMERICA AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 110. LATIN AMERICA AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 111. LATIN AMERICA AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 112. LATIN AMERICA AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2032 (USD MILLION)
TABLE 113. LATIN AMERICA AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2032 (USD MILLION)
TABLE 114. LATIN AMERICA AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2032 (USD MILLION)
TABLE 115. LATIN AMERICA AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 116. LATIN AMERICA AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2032 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2032 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2032 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 127. EUROPE AZITHROMYCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 128. EUROPE AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 129. EUROPE AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 130. EUROPE AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 131. EUROPE AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 132. EUROPE AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2032 (USD MILLION)
TABLE 133. EUROPE AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2032 (USD MILLION)
TABLE 134. EUROPE AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2032 (USD MILLION)
TABLE 135. EUROPE AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 136. EUROPE AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 137. MIDDLE EAST AZITHROMYCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 138. MIDDLE EAST AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 139. MIDDLE EAST AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 140. MIDDLE EAST AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 141. MIDDLE EAST AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 142. MIDDLE EAST AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2032 (USD MILLION)
TABLE 143. MIDDLE EAST AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2032 (USD MILLION)
TABLE 144. MIDDLE EAST AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2032 (USD MILLION)
TABLE 145. MIDDLE EAST AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 146. MIDDLE EAST AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 147. AFRICA AZITHROMYCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 148. AFRICA AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 149. AFRICA AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 150. AFRICA AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 151. AFRICA AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 152. AFRICA AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2032 (USD MILLION)
TABLE 153. AFRICA AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2032 (USD MILLION)
TABLE 154. AFRICA AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2032 (USD MILLION)
TABLE 155. AFRICA AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 156. AFRICA AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 157. ASIA-PACIFIC AZITHROMYCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 158. ASIA-PACIFIC AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 159. ASIA-PACIFIC AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 160. ASIA-PACIFIC AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 161. ASIA-PACIFIC AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 162. ASIA-PACIFIC AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2032 (USD MILLION)
TABLE 163. ASIA-PACIFIC AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2032 (USD MILLION)
TABLE 164. ASIA-PACIFIC AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2032 (USD MILLION)
TABLE 165. ASIA-PACIFIC AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 166. ASIA-PACIFIC AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 167. GLOBAL AZITHROMYCIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 168. ASEAN AZITHROMYCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 169. ASEAN AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 170. ASEAN AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 171. ASEAN AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 172. ASEAN AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 173. ASEAN AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2032 (USD MILLION)
TABLE 174. ASEAN AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2032 (USD MILLION)
TABLE 175. ASEAN AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2032 (USD MILLION)
TABLE 176. ASEAN AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 177. ASEAN AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 178. GCC AZITHROMYCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 179. GCC AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 180. GCC AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 181. GCC AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 182. GCC AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 183. GCC AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2032 (USD MILLION)
TABLE 184. GCC AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2032 (USD MILLION)
TABLE 185. GCC AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2032 (USD MILLION)
TABLE 186. GCC AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 187. GCC AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 188. EUROPEAN UNION AZITHROMYCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 189. EUROPEAN UNION AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 190. EUROPEAN UNION AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 191. EUROPEAN UNION AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 192. EUROPEAN UNION AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 193. EUROPEAN UNION AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2032 (USD MILLION)
TABLE 194. EUROPEAN UNION AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2032 (USD MILLION)
TABLE 195. EUROPEAN UNION AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2032 (USD MILLION)
TABLE 196. EUROPEAN UNION AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 197. EUROPEAN UNION AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 198. BRICS AZITHROMYCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 199. BRICS AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 200. BRICS AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 201. BRICS AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 202. BRICS AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 203. BRICS AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2032 (USD MILLION)
TABLE 204. BRICS AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2032 (USD MILLION)
TABLE 205. BRICS AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2032 (USD MILLION)
TABLE 206. BRICS AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 207. BRICS AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 208. G7 AZITHROMYCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 209. G7 AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 210. G7 AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 211. G7 AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 212. G7 AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 213. G7 AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2032 (USD MILLION)
TABLE 214. G7 AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2032 (USD MILLION)
TABLE 215. G7 AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2032 (USD MILLION)
TABLE 216. G7 AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 217. G7 AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 218. NATO AZITHROMYCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 219. NATO AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 220. NATO AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 221. NATO AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 222. NATO AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 223. NATO AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2032 (USD MILLION)
TABLE 224. NATO AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2032 (USD MILLION)
TABLE 225. NATO AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2032 (USD MILLION)
TABLE 226. NATO AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 227. NATO AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 228. GLOBAL AZITHROMYCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 229. UNITED STATES AZITHROMYCIN MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 230. UNITED STATES AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 231. UNITED STATES AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 232. UNITED STATES AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 233. UNITED STATES AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 234. UNITED STATES AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2032 (USD MILLION)
TABLE 235. UNITED STATES AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2032 (USD MILLION)
TABLE 236. UNITED STATES AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2032 (USD MILLION)
TABLE 237. UNITED STATES AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 238. UNITED STATES AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 239. CHINA AZITHROMYCIN MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 240. CHINA AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 241. CHINA AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 242. CHINA AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 243. CHINA AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 244. CHINA AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2032 (USD MILLION)
TABLE 245. CHINA AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2032 (USD MILLION)
TABLE 246. CHINA AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2032 (USD MILLION)
TABLE 247. CHINA AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 248. CHINA AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)

Companies Mentioned

  • Aurobindo Pharma
  • Cipla Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • Hikma Pharmaceuticals PLC
  • Lupin Limited
  • Lupin Limited
  • Pfizer Inc.
  • Sandoz International GmbH
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Zydus Lifesciences Ltd.

Table Information

Report AttributeDetails
No. of Pages184
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 8.28 Billion
Forecasted Market Value ( USD ) by 2032 $ 11.68 Billion
Compound Annual Growth Rate5.8%
Regions CoveredGlobal
No. of Companies Mentioned12

Related Topics

Related Reports

Azithromycin Dihydrate Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Azithromycin Dihydrate Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 181 Pages
  • Global
From
Azithromycin Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application - Product Image

Azithromycin Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application

  • Report
  • 90 Pages
  • Global
From
Azithromycin (CAS 83905-01-5) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Azithromycin (CAS 83905-01-5) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
India Azithromycin Market, By Region, Competition, Forecast and Opportunities, 2020-2030F - Product Image

India Azithromycin Market, By Region, Competition, Forecast and Opportunities, 2020-2030F

  • Report
  • 88 Pages
  • India
From
Macrolide Antibiotics Market Report 2025 - Product Image

Macrolide Antibiotics Market Report 2025

  • Report
  • 200 Pages
  • Global
From

About the Azithromycin Market

Azithromycin is an antibiotic used to treat a wide range of bacterial infections. It is a macrolide-type antibiotic, which works by stopping the growth of bacteria. Azithromycin is commonly used to treat respiratory infections, skin infections, ear infections, and sexually transmitted diseases. It is also used to prevent certain bacterial infections in people with weakened immune systems. Azithromycin is available in both oral and intravenous forms, and is often prescribed in combination with other antibiotics. Azithromycin is one of the most widely prescribed antibiotics in the world. It is generally well-tolerated and has a low risk of side effects. It is also relatively inexpensive, making it an attractive option for many patients. The azithromycin market is highly competitive, with many companies offering generic versions of the drug. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and Novartis. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.